Quantcast

Business News Archive - May 19, 2006

PARIS (Reuters) - French drug maker Sanofi-Aventis confirmed on Friday it was in talks with the U.S. Food and Drug Administration about its antibiotic Ketek following a report the U.S. regulator wanted a warning label on the drug.